| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/14/2008 | US20080038205 Novel dermatophagoides proteins |
| 02/14/2008 | US20080038201 Global regulator of morphogenesis and pathogenicity in dimorphic fungi and uses thereof |
| 02/14/2008 | US20080038193 Antibodies for use in targeted and temporary treatment of humans and animals |
| 02/14/2008 | US20080038189 RNA interference mediated inhibition of aurorakinase B and its combinations as anticancer therapy |
| 02/14/2008 | CA2695306A1 Genes and proteins of brachyspira hyodysenteriae and uses thereof |
| 02/14/2008 | CA2662569A1 Process for preparing live smallpox vaccine |
| 02/14/2008 | CA2661446A1 Treatment of pulmonary disease conditions |
| 02/14/2008 | CA2660605A1 Immunogenic peptides and their use in immune disorders |
| 02/14/2008 | CA2660375A1 Attenuated polioviruses |
| 02/14/2008 | CA2660356A1 Methods of treating multiple myeloma using combination therapies based on anti-cs1 antibodies |
| 02/14/2008 | CA2660330A1 Novel monoclonal antibody and use of the same |
| 02/14/2008 | CA2660324A1 Plasmids with immunological action |
| 02/14/2008 | CA2660235A1 Therapeutic methods for treating vascular eye disorders with dll4 antagonists |
| 02/14/2008 | CA2660102A1 Compositions and methods using anti-cs1 antibodies to treat multiple myeloma |
| 02/14/2008 | CA2659820A1 Ephb3-specific antibody and uses thereof |
| 02/14/2008 | CA2659774A1 Use of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment of mantle cell lymphomas |
| 02/14/2008 | CA2659631A1 Antibodies to erbb2 |
| 02/14/2008 | CA2657763A1 Anti-il-6 monoclonal antibodies and uses thereof |
| 02/14/2008 | CA2656222A1 Fc.gamma.riib-specific antibodies and methods of use thereof |
| 02/13/2008 | EP1887084A1 Plasmids with immunological action |
| 02/13/2008 | EP1887082A2 TADG-15: An extracellular serine protease overexpressed in carcinomas |
| 02/13/2008 | EP1887016A1 Fragments of human chorionic gonadotropin (hcg) as immunoregulator |
| 02/13/2008 | EP1887014A1 Human toll homologues |
| 02/13/2008 | EP1885893A2 Method of determining immune enhancement of virus infectivity using fc receptor-transfected cell lines |
| 02/13/2008 | EP1885888A2 Methods and compositions for pdgf-d activation and inhibition |
| 02/13/2008 | EP1885872A1 Compositions and methods for treating hemostasis disorders associated with clec-2 signal transduction |
| 02/13/2008 | EP1885815A1 Molecular glue |
| 02/13/2008 | EP1885756A2 Vascular disease therapies |
| 02/13/2008 | EP1885755A2 Anti-cd19 antibody therapy for autoimmune disease |
| 02/13/2008 | EP1885745A2 Use of h11 protein in in vitro diagnosis of streptococcus pyogenes infections |
| 02/13/2008 | EP1885734A2 Immunogens for meningitidis-a vaccines |
| 02/13/2008 | EP1885402A2 Antibodies against mammalian metapneumovirus |
| 02/13/2008 | EP1885401A2 Anti-adhesin based passive immunoprophylactic |
| 02/13/2008 | EP1885400A2 Methods of treating brain tumors with antibodies |
| 02/13/2008 | EP1885399A2 Humanized anti-cd40 antibodies and their methods of use |
| 02/13/2008 | EP1885398A1 Inhibition of the alternative complement pathway for treatment of traumatic brain injury, spinal cord injury and related conditions |
| 02/13/2008 | EP1885397A2 Use of tnf inhibitor for treatment of erosive polyarthritis |
| 02/13/2008 | EP1885395A2 A method for improving the immunogenicity of plasmodium antigens |
| 02/13/2008 | EP1885394A2 Production of multivalent virus like particles |
| 02/13/2008 | EP1885393A2 Methods and compositions for immunizing against chlamydia infection |
| 02/13/2008 | EP1885388A2 Treating and evaluating inflammatory disorders |
| 02/13/2008 | EP1885337A2 Medicament, particularly an anti-cancer medicament, for treatment using immunotherapy, particularly autologous |
| 02/13/2008 | EP1885335A1 Surface-modified microparticles and methods of forming and using the same |
| 02/13/2008 | EP1885173A2 Chloroplasts engineered to express pharmaceutical proteins |
| 02/13/2008 | EP1543109B1 Substances for preventing and treating autoimmune diseases |
| 02/13/2008 | EP1299420B1 Composition for pharmaceutical and cosmetic products |
| 02/13/2008 | EP1292328B1 Chimeric human papillomavirus (hpv) l1 molecules and uses therefor |
| 02/13/2008 | EP1248646B1 Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another enteric pathogen |
| 02/13/2008 | EP0952771B1 Novel saponin compositions and uses thereof |
| 02/13/2008 | EP0906335B1 Ebv type b ctl epitopes |
| 02/13/2008 | EP0837928B1 Recombinant poxvirus - cytomegalovirus compositions and uses |
| 02/13/2008 | EP0770138B1 Mycobacteria functional screening and/or expression vectors |
| 02/13/2008 | CN101124343A Apparatus and method for transdermal delivery of influenza vaccine |
| 02/13/2008 | CN101124327A Modified CEA/B7 vector |
| 02/13/2008 | CN101124245A Neonatal Fc receptor (FcRn)-binding polypeptide variants, dimeric Fc binding proteins and methods related thereto |
| 02/13/2008 | CN101124241A Lawsonia intracellularis 26 kd subunit vaccine |
| 02/13/2008 | CN101124240A Specific binding agents to hepatocyte growth factor |
| 02/13/2008 | CN101124239A Modulation of ovulation |
| 02/13/2008 | CN101124237A Surface proteins of streptococcus pyogenes |
| 02/13/2008 | CN101124014A Mucosal immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant |
| 02/13/2008 | CN101123984A Implantable device |
| 02/13/2008 | CN101123983A Modulation of antibody specificity by tailoring the affinity to cognate antigens |
| 02/13/2008 | CN101123982A Lipid and nitrous oxide combination as adjuvant for the enhancement of the efficacy of vaccines |
| 02/13/2008 | CN101123981A Improved DNA immunization with recombinase/transposase |
| 02/13/2008 | CN101123980A Method of treating staphylococcus aureus infection |
| 02/13/2008 | CN101123972A Methods for protein production |
| 02/13/2008 | CN101121937A Colibacillus gene engineering bacterin K88-K99-LT for firstborn piglet diarrhea and construction method thereof |
| 02/13/2008 | CN101121936A Colibacillus gene engineering bacterin 987P-ST-F41 for firstborn piglet diarrhea and construction method thereof |
| 02/13/2008 | CN101121754A Novel immunogenic lipopeptides comprising T-helper and B-cell epitopes |
| 02/13/2008 | CN101121750A Humanized anti-erbb2 antidbodies and treatment with anti-erbb2 antibodies |
| 02/13/2008 | CN101121749A Gamma-1 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
| 02/13/2008 | CN101121023A Polynucleotide vaccine formula for treating porcine respiratory and reproductive diseases |
| 02/13/2008 | CN101121021A Humanized anti-ErbB2 antidbodies and treatment with anti-ErbB2 antibodies |
| 02/13/2008 | CN101121020A Anti-gp39 antibodies and its uses |
| 02/13/2008 | CN100368527C Low toxic bacterial strain of Pasteurella multocid B26-T1200 |
| 02/13/2008 | CN100368436C Molecular design and prepn process of recombinant polyepitope chimeric peptide CP22 antigen of human chorionic gonadotropin |
| 02/13/2008 | CN100368020C Compositions for stimulating cytokine secretion and inducing an immune response |
| 02/13/2008 | CN100368019C Chitin-sodium alginate packed pylorus helicobacterium protein microballs and their preparation |
| 02/12/2008 | US7329745 Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth |
| 02/12/2008 | US7329738 Assays for detection of Bacillus anthracis |
| 02/12/2008 | US7329737 Human tissue kallikreins; asthma, chronic obstructive pulmonary disease (COPD), multiple sclerosis, psoriasis, rheumatoid arthritis, osteopathic arthritis, osteoarthritis, rhinitis, sinusitus, inflammatory bowel diseases (such as Crohn's disease and ulcerative colitis), immune mediated diabetes |
| 02/12/2008 | US7329732 HCV RNA-dependent RNA polymerase |
| 02/12/2008 | US7329639 Containing one or more epitopes recognized by and binding to a BAT monoclonal antibody; diagnosing and treating cancer; cancer vaccines |
| 02/12/2008 | US7329638 Drug delivery compositions |
| 02/12/2008 | US7329513 High level constitutive production of anthrax protective antigen |
| 02/12/2008 | US7329512 found in natural rubber that can induce an allergic reaction in persons who have been sensitised to it; for determining molecular weight, isoelectric point, amino acid sequence and allergenicity; for immunoassay/therapy |
| 02/12/2008 | US7329500 Moraxella (Branhamella) catarrhalis polypeptides and corresponding DNA fragments |
| 02/12/2008 | US7329499 Use of a novel human ULIP6/CRMP protein in diagnosis of paraneoplastic neurological syndromes |
| 02/12/2008 | US7329486 High-throughput assay for virus entry and drug screening |
| 02/12/2008 | US7329410 Compositions and method for WT1 specific immunotherapy |
| 02/12/2008 | US7329409 Immunology response intensifiers; administering a bacterial lysate, for inducing an immune response to Staphylococcus aureus infections |
| 02/12/2008 | US7329408 Eliciting HCV-specific antibodies |
| 02/12/2008 | US7329407 Recombinant herpesvirus and polyvalent vaccine |
| 02/12/2008 | US7329406 Methods of treating psoriasis with αvβ3-specific antibodies |
| 02/12/2008 | US7329405 Can be produced in a transfectoma or in a non-human transgenic animal capable of producing multiple isotypes of human monoclonal antibodies by undergoing V-D-J recombination and isotype switching |
| 02/12/2008 | US7329404 Antibodies against PRO1310 |
| 02/12/2008 | CA2275259C Formulations of recombinant papillomavirus vaccines |
| 02/12/2008 | CA2172778C Cgrp antagonist used for the treatment of lichen and pruritus; composition thus produced |
| 02/12/2008 | CA2163196C Regulation of antigen presentation |
| 02/12/2008 | CA2156273C Allogeneic vaccine and methods to synthesize same |